Capricor Therapeutics Inc CAPR
$6.65
+57.96%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 10-Q | 10-Q | 2026-08-14 | View → |
| 8-K | 8-K | 2026-08-13 | View → |
| 8-K | 8-K | 2026-07-30 | View → |
| 8-K | 8-K | 2026-07-29 | View → |
| 8-K | 8-K | 2026-07-14 | View → |
| 4 | Insider transaction | 2026-06-29 | View → |
| 4 | Insider transaction | 2026-06-29 | View → |
| 8-K | 8-K | 2026-06-26 | View → |
| 4 | Insider transaction | 2026-06-24 | View → |
| 4 | Insider transaction | 2026-06-24 | View → |
| 8-K | 8-K | 2026-06-08 | View → |
| 4 | Insider transaction | 2026-05-28 | View → |
| 4 | Insider transaction | 2026-05-19 | View → |
| 4 | Insider transaction | 2026-05-14 | View → |
| 10-Q | 10-Q | 2026-05-13 | View → |
| 8-K | 8-K | 2026-05-12 | View → |
| 8-K | 8-K | 2026-05-07 | View → |
| 4 | Insider transaction | 2026-05-04 | View → |
| 4 | Insider transaction | 2026-05-04 | View → |
| DEF 14A | DEF 14A | 2026-04-10 | View → |
| 4 | Insider transaction | 2026-04-03 | View → |
| 4 | Insider transaction | 2026-04-01 | View → |
| 4 | Insider transaction | 2026-04-01 | View → |
| 4 | Insider transaction | 2026-04-01 | View → |
| 4 | Insider transaction | 2026-03-27 | View → |
| 10-K | 10-K | 2026-03-17 | View → |
| 8-K | 8-K | 2026-03-12 | View → |
| 8-K | 8-K | 2026-03-10 | View → |
| 4 | Insider transaction | 2026-01-07 | View → |
| 4 | Insider transaction | 2026-01-07 | View → |
| 4 | Insider transaction | 2026-01-07 | View → |
| 4 | Insider transaction | 2026-01-07 | View → |
| 4 | Insider transaction | 2026-01-07 | View → |
| 4 | Insider transaction | 2026-01-07 | View → |
| 4 | Insider transaction | 2026-01-07 | View → |
| 4 | Insider transaction | 2026-01-07 | View → |
| 4 | Insider transaction | 2026-01-07 | View → |
| 4 | Insider transaction | 2026-01-07 | View → |
| 4 | Insider transaction | 2025-12-23 | View → |
| 424B5 | 424B5 | 2025-12-05 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $6.65
- Market Cap
- $242.65 million
- 52-Week Range
- $2.96 – $40.37
- Average Volume
- 7.35 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.